Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-14 Tax Withholding | 2024-11-18 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 368 | $7.92 | 26,522 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:51 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 368 | $7.02 | 26,890 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 7:00 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 368 | $8.36 | 27,258 (Direct) | View |
| 2024-02-14 Tax Withholding | 2024-02-16 5:12 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 434 | $3.4 | 27,626 (Direct) | View |
| 2023-11-14 Tax Withholding | 2023-11-16 7:42 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 1,470 | $5.08 | 28,060 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-20 5:21 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 9,500 | $3.63 | 212,649 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-20 5:21 pm | N/A 2032-06-28 | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 9,500 | $0 | 212,649 (Direct) | View |
| 2022-11-14 Option Award | 2022-11-16 7:13 pm | N/A 2032-11-13 | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 80,120 | $0 | 80,120 (Direct) | View |
Ownership | 2022-11-09 8:30 pm | N/A 2032-06-28 | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 0 | $0 | 192,619 (Direct) | View |